Superstring Capital Management Lp
Source: SEC Form 13F · as of Mar 2026Superstring Capital Management Lp holds 20 biotech & pharma companies tracked by BioSniper, totaling $93.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$93.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Summit Therapeutics Inc. (SMMT)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| SMMTSummit Therapeutics Inc. | 892,873 | $16.9M |
| IMVTImmunovant, Inc. | 357,606 | $8.9M |
| COGTCogent Biosciences, Inc. | 225,158 | $8.7M |
| SVRASavara Inc | 1,585,977 | $8.7M |
| DFTXDefinium Therapeutics Inc. | 351,461 | $6.6M |
| PCVXVaxcyte, Inc. | 110,454 | $6.4M |
| CLDXCelldex Therapeutics, Inc. | 180,048 | $5.7M |
| SIONSionna Therapeutics, Inc. | 141,024 | $5.7M |
| GMABGenmab A/S | 196,709 | $5.3M |
| MPLTMapLight Therapeutics, Inc. | 192,139 | $3.9M |
| ARVNARVINAS, INC. | 312,620 | $3.3M |
| ORKAOruka Therapeutics, Inc. | 63,591 | $3.1M |
| TVTXTravere Therapeutics, Inc. | 102,754 | $3.1M |
| AXSMAxsome Therapeutics, Inc. | 11,217 | $1.9M |
| ORICOric Pharmaceuticals, Inc. | 115,234 | $1.5M |
| CLYMClimb Bio, Inc. | 199,209 | $1.4M |
| TNXPTonix Pharmaceuticals Holding Corp. | 63,540 | $874K |
| CGEMCullinan Therapeutics, Inc. | 59,484 | $845K |
| PTNPALATIN TECHNOLOGIES INC | 35,969 | $627K |
| BMEABiomea Fusion, Inc. | 250,000 | $383K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.